Compound name
Imatinib
Alt Name
Imatinib Methansulfonate
sti-571
Cgp 57148
Imatinib free base
Gleevec
Compound Image
Imatinib.png
SMILES
CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5
MW
493.60
Brutto
C29H31N7O
InChI
InChI=1S/C29H31N7O/c1-21-5-10-25(18-27(21)34-29-31-13-11-26(33-29)24-4-3-12-30-19-24)32-28(37)23-8-6-22(7-9-23)20-36-16-14-35(2)15-17-36/h3-13,18-19H,14-17,20H2,1-2H3,(H,32,37)(H,31,33,34)
InChI Key
KTUFNOKKBVMGRW-UHFFFAOYSA-N
Approval Jurisdiction
2001 FDA
Approved for clinical use
Chronic Myelogenous Leukemia
CAS
152459-95-5
PubChem CID
5291
Action
BCR-ABL, c-KIT, PDGFR
Approved Drug List
1
Patent
<a href="http://www.wipo.int/patentscope/search/en/result.jsf?query=ALLNUM%3AWO2006039533">WO2006039533</a>
Commercial Vendor
Novartis
Reference 2